EPISODE · Jun 21, 2022 · 5 MIN
BRAIN Biotech AG ESG | Targets, Opportunities and Key Points with IR
from Investor Insights from CEOs & CFOs | seat11a · host seat11a.com
BRAIN Biotech AG ESG: Key Takeaways Welcome to Our Video Feature Welcome to our video featuring Michael Schneiders, the Head of Investor Relations at Brain Biotech AG. Join him as he presents on ESG (Environmental, Social, and Governance) and guides you through five key points of ESG+, targets for 2032/2050, and the opportunities that ESG presents. ESG Presentation by Michael Schneiders Other videos: Elevator Pitch Company Presentation Deep Dive Presentation Financial Results Presentation ESG Presentation T&C: This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Embed this episode
Ready to play
BRAIN Biotech AG ESG | Targets, Opportunities and Key Points with IR
No transcript for this episode yet
Similar Episodes
No similar episodes found.